5th Street Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
5th Street Advisors's XBI Position: Q2 2026 in Review
5th Street Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.9% in Q2 2026, buying an estimated $46.8K and bringing the position to 18,911 shares worth $2.99M. The position accounts for 1.14% of the portfolio, ranked #24.
5th Street Advisors first reported a position in XBI in Q1 2025 and has held it in 6 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- 5th Street Advisors held 18,911 shares of State Street SPDR S&P Biotech ETF worth $2.99M as of Q2 2026.
- 5th Street Advisors bought 346 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $46.8K.
- State Street SPDR S&P Biotech ETF made up 1.14% of 5th Street Advisors's portfolio in Q2 2026, its #24 holding.
- 5th Street Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 6 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on 5th Street Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.